{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "clinical", "medicinal plants", "phytochemicals", "preclinical"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32116665", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "28"}], "Language": ["eng"], "ELocationID": ["1614", "10.3389/fphar.2019.01614"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2019"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.", "Pagination": {"StartPage": "1614", "MedlinePgn": "1614"}, "Abstract": {"AbstractText": ["Cancer is a severe health problem that continues to be a leading cause of death worldwide. Increasing knowledge of the molecular mechanisms underlying cancer progression has led to the development of a vast number of anticancer drugs. However, the use of chemically synthesized drugs has not significantly improved the overall survival rate over the past few decades. As a result, new strategies and novel chemoprevention agents are needed to complement current cancer therapies to improve efficiency. Naturally occurring compounds from plants known as phytochemicals, serve as vital resources for novel drugs and are also sources for cancer therapy. Some typical examples include taxol analogs, vinca alkaloids such as vincristine, vinblastine, and podophyllotoxin analogs. These phytochemicals often act <i>via</i> regulating molecular pathways which are implicated in growth and progression of cancer. The specific mechanisms include increasing antioxidant status, carcinogen inactivation, inhibiting proliferation, induction of cell cycle arrest and apoptosis; and regulation of the immune system. The primary objective of this review is to describe what we know to date of the active compounds in the natural products, along with their pharmacologic action and molecular or specific targets. Recent trends and gaps in phytochemical based anticancer drug discovery are also explored. The authors wish to expand the phytochemical research area not only for their scientific soundness but also for their potential druggability. Hence, the emphasis is given to information about anticancer phytochemicals which are evaluated at preclinical and clinical level."], "CopyrightInformation": "Copyright \u00a9 2020 Choudhari, Mandave, Deshpande, Ranjekar and Prakash."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Combi-Chem Bio-Resource Center, Organic Chemistry Division, CSIR-National Chemical Laboratory, Pune, India."}], "LastName": "Choudhari", "ForeName": "Amit S", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Interactive Research School of Health Affairs, Bharati Vidyapeeth Deemed University, Pune, India."}], "LastName": "Mandave", "ForeName": "Pallavi C", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dravyaguna Vigan, Ayurved Pharmacology, College of Ayurved, Bharati Vidyapeeth Deemed University, Pune, India."}], "LastName": "Deshpande", "ForeName": "Manasi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Innovation Biologicals Pvt. Ltd., Pune, India."}], "LastName": "Ranjekar", "ForeName": "Prabhakar", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States."}, {"Identifier": [], "Affiliation": "Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States."}], "LastName": "Prakash", "ForeName": "Om", "Initials": "O"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CommentsCorrectionsList": [{"RefSource": "Front Pharmacol. 2020 Feb 28;11:175. doi: 10.3389/fphar.2020.00175", "PMID": "32184731"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abrams S. L., Follo M. Y., Steelman L. S., Lertpiriyapong K., Cocco L., Ratti S., et al. (2019). Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Adv. Biol. Regul. 71, 172\u2013182. 10.1016/j.jbior.2018.10.003", "ArticleIdList": ["10.1016/j.jbior.2018.10.003", "30361003"]}, {"Citation": "Adams L. S., Phung S., Yee N., Seeram N. P., Li L., Chen S. (2010). Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. 70 (9), 3594\u20133605. 10.1158/0008-5472.CAN-09-3565", "ArticleIdList": ["10.1158/0008-5472.CAN-09-3565", "PMC2862148", "20388778"]}, {"Citation": "Alumkal J. J., Slottke R., Schwartzman J., Cherala G., Munar M., Graff J. N., et al. (2015). A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest. New Drugs 33 (2), 480\u2013489. 10.1007/s10637-014-0189-z", "ArticleIdList": ["10.1007/s10637-014-0189-z", "PMC4390425", "25431127"]}, {"Citation": "Aras D., Cinar O., Cakar Z., Ozkavukcu S., Can A. (2016). Can dicoumarol be used as a gonad-safe anticancer agent: an in vitro and in vivo experimental study. Mol. Hum. Reprod. 22 (1), 57\u201367. 10.1093/molehr/gav065", "ArticleIdList": ["10.1093/molehr/gav065", "26612783"]}, {"Citation": "Banerjee S., Bueso-Ramos C., Aggarwal B. B. (2002). Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-\u03baB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62, 4945\u20134954.", "ArticleIdList": ["12208745"]}, {"Citation": "Bayet-Robert M., Kwiatkowski F., Leheurteur M., Gachon F., Planchat E., Abrial C., et al. (2010). Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol. Ther. 9 (1), 8\u201314. 10.4161/cbt.9.1.10392", "ArticleIdList": ["10.4161/cbt.9.1.10392", "19901561"]}, {"Citation": "Beynon R. A., Richmond R. C., Santos Ferreira D. L., Ness A. R., May M., Smith G. D., et al. (2019). Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial. Int. J. Cancer 144 (8), 1918\u20131928. 10.1002/ijc.31929", "ArticleIdList": ["10.1002/ijc.31929", "PMC6491994", "30325021"]}, {"Citation": "Bhattacharya S., Mondal L., Mukherjee B., Dutta L., Ehsan I., Debnath M. C., et al. (2018). Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomedicine 14 (6), 1905\u20131917. 10.1016/j.nano.2018.05.011", "ArticleIdList": ["10.1016/j.nano.2018.05.011", "29802937"]}, {"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68 (6), 394\u2013424. 10.3322/caac.21492", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Butler M. S. (2004). The role of natural product chemistry in drug discovery. J. Nat. Prod. 67 (12), 2141\u20132153. 10.1021/np040106y", "ArticleIdList": ["10.1021/np040106y", "15620274"]}, {"Citation": "Cao B., Chen H., Gao Y., Niu C., Zhang Y., Li L. (2015). CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro . Int. J. Mol. Med. 35 (3), 771\u2013776. 10.3892/ijmm.2015.2068", "ArticleIdList": ["10.3892/ijmm.2015.2068", "25592869"]}, {"Citation": "Carroll R. E., Benya R. V., Turgeon D. K., Vareed S., Neuman M., Rodriguez L., et al. (2011). Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. (Phila) 4 (3), 354\u2013364. 10.1158/1940-6207.CAPR-10-0098", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0098", "PMC4136551", "21372035"]}, {"Citation": "Chang J. H., Cheng C. W., Yang Y. C., Chen W. S., Hung W. Y., Chow J. M., et al. (2018). Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. J. Exp. Clin. Cancer Res. 37 (1), 199. 10.1186/s13046-018-0869-1", "ArticleIdList": ["10.1186/s13046-018-0869-1", "PMC6104010", "30134935"]}, {"Citation": "Chen J., Song Y., Zhang L. (2013). Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J. Nutr. Sci. Vitaminol (Tokyo) 59 (3), 213\u2013223. 10.3177/jnsv.59.213", "ArticleIdList": ["10.3177/jnsv.59.213", "23883692"]}, {"Citation": "Chen L., Xia G., Qiu F., Wu C., Denmon A. P., Zi X. (2016). Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2alpha and inhibits tumor growth. Sci. Rep. 6, 32582. 10.1038/srep32582", "ArticleIdList": ["10.1038/srep32582", "PMC5007653", "27581364"]}, {"Citation": "Chen H., Zhu B., Zhao L., Liu Y., Zhao F., Feng J., et al. (2018). Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. Cell Physiol. Biochem. 47 (2), 641\u2013653. 10.1159/000490019", "ArticleIdList": ["10.1159/000490019", "29794468"]}, {"Citation": "Choi B. Y., Kim B. W. (2015). Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity. J. Cancer Prev. 20 (3), 185\u2013192. 10.15430/JCP.2015.20.3.185", "ArticleIdList": ["10.15430/JCP.2015.20.3.185", "PMC4597807", "26473157"]}, {"Citation": "Choi Y. J., Heo K., Park H. S., Yang K. M., Jeong M. H. (2016). The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions. Int. J. Oncol. 49 (4), 1479\u20131488. 10.3892/ijo.2016.3647", "ArticleIdList": ["10.3892/ijo.2016.3647", "27498957"]}, {"Citation": "Cipolla B. G., Mandron E., Lefort J. M., Coadou Y., Della Negra E., Corbel L., et al. (2015). Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy. Cancer Prev. Res. (Phila) 8 (8), 712\u2013719. 10.1158/1940-6207.CAPR-14-0459", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0459", "25968598"]}, {"Citation": "Cojocneanu P. R., Braicu C., Raduly L., Zanoaga O., Dragos N., Monroig P., et al. (2015). Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers. Onco. Targets Ther. 8, 2053\u20132066. 10.2147/OTT.S83597", "ArticleIdList": ["10.2147/OTT.S83597", "PMC4532173", "26273208"]}, {"Citation": "Darvesh A. S., Aggarwal B. B., Bishayee A. (2012). Curcumin and liver cancer: a review. Curr. Pharm. Biotechnol. 13 (1), 218\u2013228. 10.2174/138920112798868791", "ArticleIdList": ["10.2174/138920112798868791", "21466422"]}, {"Citation": "Das A. M. (2017). Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1). Appl. Clin. Genet. 10, 43\u201348. 10.2147/TACG.S113310", "ArticleIdList": ["10.2147/TACG.S113310", "PMC5533484", "28769581"]}, {"Citation": "De La Chapa J. J., Singha P. K., Lee D. R., Gonzales C. B. (2018). Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis. J. Pathol. Med. 47 (7), 674\u2013682. 10.1111/jop.12735", "ArticleIdList": ["10.1111/jop.12735", "PMC6105452", "29777637"]}, {"Citation": "de Lima R. M. T., Dos Reis A. C., de Menezes A. P. M., Santos J. V. O., Filho J., Ferreira J. R. O., et al. (2018). Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review. Phytother. Res. 32 (10), 1885\u20131907. 10.1002/ptr.6134", "ArticleIdList": ["10.1002/ptr.6134", "30009484"]}, {"Citation": "Deleu D., Hanssens Y., Northway M. G. (2004). Subcutaneous apomorphine: an evidence-based review of its use in Parkinson\u2019s disease. Drugs Aging 21 (11), 687\u2013709. 10.2165/00002512-200421110-00001", "ArticleIdList": ["10.2165/00002512-200421110-00001", "15323576"]}, {"Citation": "Deng Q. P., Wang M. J., Zeng X., Chen G. G., Huang R. Y. (2017). Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma. Cell Physiol. Biochem. 41 (4), 1383\u20131392. 10.1159/000467897", "ArticleIdList": ["10.1159/000467897", "28315871"]}, {"Citation": "Ding W., Hu Z., Zhang Z., Ma Q., Tang H., Ma Z. (2015). Physapubescin B Exhibits Potent Activity against Human Prostate Cancer In Vitro and In Vivo. J. Agric. Food Chem. 63 (43), 9504\u20139512. 10.1021/acs.jafc.5b03045", "ArticleIdList": ["10.1021/acs.jafc.5b03045", "26415552"]}, {"Citation": "Doello K., Ortiz R., Alvarez P. J., Melguizo C., Cabeza L., Prados J. (2018). Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review. Nutr. Cancer 70 (4), 569\u2013578. 10.1080/01635581.2018.1464347", "ArticleIdList": ["10.1080/01635581.2018.1464347", "29708445"]}, {"Citation": "Dou J., Wang Z., Ma L., Peng B., Mao K., Li C., et al. (2018). Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 9 (28), 20089\u201320102. 10.18632/oncotarget.24015", "ArticleIdList": ["10.18632/oncotarget.24015", "PMC5929448", "29732005"]}, {"Citation": "Epelbaum R., Schaffer M., Vizel B., Badmaev V., Bar-Sela G. (2010). Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr. Cancer 62 (8), 1137\u20131141. 10.1080/01635581.2010.513802", "ArticleIdList": ["10.1080/01635581.2010.513802", "21058202"]}, {"Citation": "Feng Y., Yang Y., Fan C., Di S., Hu W., Jiang S., et al. (2016). Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress. Cell Physiol. Biochem. 38 (3), 1226\u20131244. 10.1159/000443071", "ArticleIdList": ["10.1159/000443071", "26982591"]}, {"Citation": "Fridlender M., Kapulnik Y., Koltai H. (2015). Plant derived substances with anti-cancer activity: from folklore to practice. Front. Plant Sci. 6, 799. 10.3389/fpls.2015.00799", "ArticleIdList": ["10.3389/fpls.2015.00799", "PMC4589652", "26483815"]}, {"Citation": "Fujiki H., Sueoka E., Watanabe T., Suganuma M. (2015). Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J. Cancer Prev. 20 (1), 1\u20134. 10.15430/JCP.2015.20.1.1", "ArticleIdList": ["10.15430/JCP.2015.20.1.1", "PMC4384709", "25853098"]}, {"Citation": "Gao M. Q., Gao H., Han M., Liu K. L., Peng J. J., Han Y. T. (2017). Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat. Am. J. Cancer Res. 7 (7), 1501\u20131514.", "ArticleIdList": ["PMC5523031", "28744400"]}, {"Citation": "Gee J. R., Saltzstein D. R., Kim K., Kolesar J., Huang W., Havighurst T. C., et al. (2017). A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers. Cancer Prev. Res. (Phila) 10 (5), 298\u2013307. 10.1158/1940-6207.CAPR-16-0167", "ArticleIdList": ["10.1158/1940-6207.CAPR-16-0167", "PMC5503683", "28325826"]}, {"Citation": "Ghalaut V. S., Sangwan L., Dahiya K., Ghalaut P. S., Dhankhar R., Saharan R. (2012). Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. J. Oncol. Pharm. Pract. 18 (2), 186\u2013190. 10.1177/1078155211416530", "ArticleIdList": ["10.1177/1078155211416530", "21844132"]}, {"Citation": "Gontero P., Marra G., Soria F., Oderda M., Zitella A., Baratta F., et al. (2015). A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or \u201cchemopromotion\u201d? Prostate 75 (11), 1177\u20131186. 10.1002/pros.22999", "ArticleIdList": ["10.1002/pros.22999", "25893930"]}, {"Citation": "Han M., Gao H., Xie J., Yuan Y. P., Yuan Q., Gao M. Q., et al. (2018). Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway. Acta Pharmacol. Sin. 666\u2013676. 10.1038/s41401-018-0159-7", "ArticleIdList": ["10.1038/s41401-018-0159-7", "PMC6786425", "30218072"]}, {"Citation": "Heinrich M., Lee Teoh H. (2004). Galanthamine from snowdrop\u2013the development of a modern drug against Alzheimer\u2019s disease from local Caucasian knowledge. J. Ethnopharmacol. 92 (2-3), 147\u2013162. 10.1016/j.jep.2004.02.012", "ArticleIdList": ["10.1016/j.jep.2004.02.012", "15137996"]}, {"Citation": "Hertzberg R. P., Caranfa M. J., Hecht S. M. (1989). On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28 (11), 4629\u20134638. 10.1021/bi00437a018", "ArticleIdList": ["10.1021/bi00437a018", "2548584"]}, {"Citation": "Hesari A., Ghasemi F., Cicero A. F. G., Mohajeri M., Rezaei O., Hayat S. M. G., et al. (2018). Berberine: A potential adjunct for the treatment of gastrointestinal cancers? J. Cell Biochem. 119 (12), 9655\u20139663. 10.1002/jcb.27392", "ArticleIdList": ["10.1002/jcb.27392", "30125974"]}, {"Citation": "Hou D., Xu G., Zhang C., Li B., Qin J., Hao X., et al. (2017). Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition. Cell Death Dis. 8 (10), e3070. 10.1038/cddis.2017.471", "ArticleIdList": ["10.1038/cddis.2017.471", "PMC5680592", "28981112"]}, {"Citation": "Howells L. M., Berry D. P., Elliott P. J., Jacobson E. W., Hoffmann E., Hegarty B., et al. (2011). Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2013safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. (Phila) 4 (9), 1419\u20131425. 10.1158/1940-6207.CAPR-11-0148", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0148", "PMC3173869", "21680702"]}, {"Citation": "Hsiao Y. C., Peng S. F., Lai K. C., Liao C. L., Huang Y. P., Lin C. C., et al. (2019). Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL-60 cancer cell xenograft growth in vivo . Environ. Toxicol. 34 (4), 443\u2013456. 10.1002/tox.22698", "ArticleIdList": ["10.1002/tox.22698", "30618158"]}, {"Citation": "Hu W. J., Liu J., Zhong L. K., Wang J. (2018). Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling. Biomed. Pharmacotherapy 102, 681\u2013688. 10.1016/j.biopha.2018.03.111", "ArticleIdList": ["10.1016/j.biopha.2018.03.111", "29604587"]}, {"Citation": "Huang M. T., Newmark H. L., Frenkel K. (1997). Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl. 27, 26\u201334. 10.1002/(sici)1097-4644(1997)27+<26::aid-jcb7>3.0.co;2-3", "ArticleIdList": ["10.1002/(sici)1097-4644(1997)27+<26::aid-jcb7>3.0.co;2-3", "9591190"]}, {"Citation": "Huang L., Song Y., Lian J., Wang Z. (2017). Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling. Oncol. Lett. 14 (1), 468\u2013474. 10.3892/ol.2017.6129", "ArticleIdList": ["10.3892/ol.2017.6129", "PMC5494782", "28693193"]}, {"Citation": "Irving G. R., Iwuji C. O., Morgan B., Berry D. P., Steward W. P., Thomas A., et al. (2015). Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Trials 16, 110. 10.1186/s13063-015-0641-1", "ArticleIdList": ["10.1186/s13063-015-0641-1", "PMC4392790", "25872567"]}, {"Citation": "Islam M. T., Ali E. S., Uddin S. J., Islam M. A., Shaw S., Khan I. N., et al. (2018). Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett. 420, 129\u2013145. 10.1016/j.canlet.2018.01.074", "ArticleIdList": ["10.1016/j.canlet.2018.01.074", "29408515"]}, {"Citation": "Itokawa H., Wang X., Lee K. H. (2005). Homoharringtone and related compounds (Boca Raton: CRC Press; )."}, {"Citation": "Iwanowycz S., Wang J., Hodge J., Wang Y., Yu F., Fan D. (2016). Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Mol. Cancer Ther. 15 (8), 1931\u20131942. 10.1158/1535-7163.MCT-15-0987", "ArticleIdList": ["10.1158/1535-7163.MCT-15-0987", "PMC4975665", "27196773"]}, {"Citation": "James M. I., Iwuji C., Irving G., Karmokar A., Higgins J. A., Griffin-Teal N., et al. (2015). Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. 364 (2), 135\u2013141. 10.1016/j.canlet.2015.05.005", "ArticleIdList": ["10.1016/j.canlet.2015.05.005", "PMC4510144", "25979230"]}, {"Citation": "Joo J. H., Hong S. S., Cho Y. R., Seo D. W. (2016). 10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38MAPK activity. Oncol. Rep. 35 (2), 779\u2013784. 10.3892/or.2015.4405", "ArticleIdList": ["10.3892/or.2015.4405", "26554741"]}, {"Citation": "Kanai M., Otsuka Y., Otsuka K., Sato M., Nishimura T., Mori Y., et al. (2013). A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother. Pharmacol. 71 (6), 1521\u20131530. 10.1007/s00280-013-2151-8", "ArticleIdList": ["10.1007/s00280-013-2151-8", "23543271"]}, {"Citation": "Kim M. O., Lee M. H., Oi N., Kim S. H., Bae K. B., Huang Z., et al. (2014). [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis 35 (3), 683\u2013691. 10.1093/carcin/bgt365", "ArticleIdList": ["10.1093/carcin/bgt365", "PMC3941745", "24282290"]}, {"Citation": "Kim D. H., Sung B., Kim J. A., Kang Y. J., Hwang S. Y., Hwang N. L., et al. (2017). HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model. Int. J. Oncol. 51 (2), 715\u2013723. 10.3892/ijo.2017.4058", "ArticleIdList": ["10.3892/ijo.2017.4058", "28656256"]}, {"Citation": "Kimura Y., Okuda H. (2001). Resveratrol isolated from polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J. Nutr. 131 (6), 1844\u20131849. 10.1093/jn/131.6.1844", "ArticleIdList": ["10.1093/jn/131.6.1844", "11385077"]}, {"Citation": "Kiselev V. I., Ashrafyan L. A., Muyzhnek E. L., Gerfanova E. V., Antonova I. B., Aleshikova O. I., et al. (2018). A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study. BMC Cancer 18 (1), 904. 10.1186/s12885-018-4792-9", "ArticleIdList": ["10.1186/s12885-018-4792-9", "PMC6148762", "30236079"]}, {"Citation": "Kong Y., Chen G., Xu Z., Yang G., Li B., Wu X., et al. (2016). Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci. Rep. 6, 37417. 10.1038/srep37417", "ArticleIdList": ["10.1038/srep37417", "PMC5116667", "27869173"]}, {"Citation": "Kotsakis A., Matikas A., Koinis F., Kentepozidis N., Varthalitis I. I., Karavassilis V., et al. (2016). A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy. Br. J. Cancer 115 (7), 784\u2013788. 10.1038/bjc.2016.281", "ArticleIdList": ["10.1038/bjc.2016.281", "PMC5046219", "27607471"]}, {"Citation": "Kumar N. B., Pow-Sang J., Spiess P. E., Park J., Salup R., Williams C. R., et al. (2016). Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins. Oncotarget 7 (43), 70794\u201370802. 10.18632/oncotarget.12222", "ArticleIdList": ["10.18632/oncotarget.12222", "PMC5340117", "28053292"]}, {"Citation": "Kunnumakkara A. B., Bordoloi D., Harsha C., Banik K., Gupta S. C., Aggarwal B. B. (2017). Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin. Sci. (Lond) 131 (15), 1781\u20131799. 10.1042/CS20160935", "ArticleIdList": ["10.1042/CS20160935", "28679846"]}, {"Citation": "Kuppusamy P., Nagalingam A., Muniraj N., Saxena N. K., Sharma D. (2017). Concomitant activation of ETS-like transcription factor-1 and death Receptor-5 via extracellular signal-regulated kinase in withaferin a-mediated inhibition of hepatocarcinogenesis in mice. Sci. Rep. 7 (1), 17943. 10.1038/s41598-017-18190-4", "ArticleIdList": ["10.1038/s41598-017-18190-4", "PMC5738353", "29263422"]}, {"Citation": "Lee W. L., Huang J. Y., Shyur L. F. (2013). Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms. Oxid. Med. Cell Longev 2013, 925804. 10.1155/2013/925804", "ArticleIdList": ["10.1155/2013/925804", "PMC3886269", "24454991"]}, {"Citation": "Li X., Huang T., Jiang G., Gong W., Qian H., Zou C. (2013). Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis. Toxicol. Lett. 221 (3), 197\u2013204. 10.1016/j.toxlet.2013.06.233", "ArticleIdList": ["10.1016/j.toxlet.2013.06.233", "23830991"]}, {"Citation": "Li J., Zhang C., Jiang H., Cheng J. (2015). Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. Onco. Targets Ther. 8, 427\u2013435. 10.2147/OTT.S76116", "ArticleIdList": ["10.2147/OTT.S76116", "PMC4335622", "25709476"]}, {"Citation": "Lin W., Zhong M., Yin H., Chen Y., Cao Q., Wang C., et al. (2016). Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo . Oncol. Rep. 36 (2), 961\u2013967. 10.3892/or.2016.4861", "ArticleIdList": ["10.3892/or.2016.4861", "27278720"]}, {"Citation": "Lin C. Y., Hsieh P. L., Liao Y. W., Peng C. Y., Lu M. Y., Yang C. H., et al. (2017). Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells. Oncotarget 8 (46), 80900\u201380908. 10.18632/oncotarget.20723", "ArticleIdList": ["10.18632/oncotarget.20723", "PMC5655248", "29113353"]}, {"Citation": "Lu L., Zhao Z., Liu L., Gong W., Dong J. (2018. a). Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo . Tradit. Med. Modern Med. 01 (03), 213\u2013218. 10.1142/S2575900018500131"}, {"Citation": "Lu W. J., Wu G. J., Chen R. J., Chang C. C., Lien L. M., Chiu C. C., et al. (2018. b). Licochalcone A attenuates glioma cell growth in vitro and in vivo through cell cycle arrest. Food Funct. 9 (8), 4500\u20134507. 10.1039/c8fo00728d", "ArticleIdList": ["10.1039/c8fo00728d", "30083664"]}, {"Citation": "Madunic J., Madunic IV, Gajski G., Popic J., Garaj-Vrhovac V. (2018). Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Lett. 413, 11\u201322. 10.1016/j.canlet.2017.10.041", "ArticleIdList": ["10.1016/j.canlet.2017.10.041", "29097249"]}, {"Citation": "Mahammedi H., Planchat E., Pouget M., Durando X., Cure H., Guy L., et al. (2016). The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: a pilot phase II study. Oncology 90 (2), 69\u201378. 10.1159/000441148", "ArticleIdList": ["10.1159/000441148", "26771576"]}, {"Citation": "Mahata S., Bharti A. C., Shukla S., Tyagi A., Husain S. A., Das B. C. (2011). Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer 10, 39. 10.1186/1476-4598-10-39", "ArticleIdList": ["10.1186/1476-4598-10-39", "PMC3098825", "21496227"]}, {"Citation": "Mao L., Chen Q., Gong K., Xu X., Xie Y., Zhang W., et al. (2018). Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells. Oncol. Rep. 39 (5), 2436\u20132442. 10.3892/or.2018.6318", "ArticleIdList": ["10.3892/or.2018.6318", "29565467"]}, {"Citation": "Martin A., Fuzer A. M., Becceneri A. B., da Silva J. A., Tomasin R., Denoyer D., et al. (2017). [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo . Oncotarget 8 (42), 72260\u201372271. 10.18632/oncotarget.20139", "ArticleIdList": ["10.18632/oncotarget.20139", "PMC5641128", "29069785"]}, {"Citation": "Martino E., Casamassima G., Castiglione S., Cellupica E., Pantalone S., Papagni F., et al. (2018). Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg. Med. Chem. Lett. 28 (17), 2816\u20132826. 10.1016/j.bmcl.2018.06.044", "ArticleIdList": ["10.1016/j.bmcl.2018.06.044", "30122223"]}, {"Citation": "Mock C. D., Jordan B. C., Selvam C. (2015). Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment. RSC Adv. 5 (92), 75575\u201375588. 10.1039/C5RA14925H", "ArticleIdList": ["10.1039/C5RA14925H", "PMC4836288", "27103993"]}, {"Citation": "Mostofa A. G. M., Hossain M. K., Basak D., Bin Sayeed M. S. (2017). Thymoquinone as a potential adjuvant therapy for cancer treatment: evidence from preclinical studies. Front. Pharmacol. 8, 295. 10.3389/fphar.2017.00295", "ArticleIdList": ["10.3389/fphar.2017.00295", "PMC5466966", "28659794"]}, {"Citation": "Mundy C., Kirkpatrick P. (2004). Tiotropium bromide. Nat. Rev. Drug Discovery 3 (8), 643\u2013644. 10.1038/nrd1472", "ArticleIdList": ["10.1038/nrd1472", "15317149"]}, {"Citation": "Nakamura K., Yasunaga Y., Segawa T., Ko D., Moul J. W., Srivastava S., et al. (2002). Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int. J. Oncol. 21 (4), 825\u2013830. 10.3892/ijo.21.4.825", "ArticleIdList": ["10.3892/ijo.21.4.825", "12239622"]}, {"Citation": "Newman D. J., Cragg G. M. (2016). Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 79 (3), 629\u2013661. 10.1021/acs.jnatprod.5b01055", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Newman D. J., Cragg G. M., Snader K. M. (2000). The influence of natural products upon drug discovery. Nat. Prod. Rep. 17 (3), 215\u2013234. 10.1039/a902202c", "ArticleIdList": ["10.1039/a902202c", "10888010"]}, {"Citation": "Nussbaumer S., Bonnabry P., Veuthey J. L., Fleury-Souverain S. (2011). Analysis of anticancer drugs: a review. Talanta 85 (5), 2265\u20132289. 10.1016/j.talanta.2011.08.034", "ArticleIdList": ["10.1016/j.talanta.2011.08.034", "21962644"]}, {"Citation": "Odeh L. H., Talib W. H., Basheti I. A. (2018). Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice. J. Cancer Res. Ther. 14 (Supplement), S324\u2013S330. 10.4103/0973-1482.235349", "ArticleIdList": ["10.4103/0973-1482.235349", "29970684"]}, {"Citation": "Ogbonna J., Kenechukwu F., Attama A., Chime S. (2012). Different approaches to formulation of herbal extracts/phytopharmaceuticals/bioactive phytochstituents - a review. Int. J. Pharm. Sci. Rev. Res. 16 (1), 1\u20138."}, {"Citation": "Oudard S., Fizazi K., Sengelov L., Daugaard G., Saad F., Hansen S., et al. (2017). Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: a randomized phase III trial-firstana. J. Clin. Oncol. 35 (28), 3189\u20133197. 10.1200/JCO.2016.72.1068", "ArticleIdList": ["10.1200/JCO.2016.72.1068", "28753384"]}, {"Citation": "Paller C. J., Rudek M. A., Zhou X. C., Wagner W. D., Hudson T. S., Anders N., et al. (2015). A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: safety, tolerability, and dose determination. Prostate 75 (14), 1518\u20131525. 10.1002/pros.23024", "ArticleIdList": ["10.1002/pros.23024", "PMC4537354", "26012728"]}, {"Citation": "Paller C. J., Zhou X. C., Heath E. I., Taplin M. E., Mayer T., Stein M. N., et al. (2018). Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: a randomized, multicenter, placebo-controlled clinical trial. Clin. Cancer Res. 24 (2), 306\u2013315. 10.1158/1078-0432.CCR-17-1100", "ArticleIdList": ["10.1158/1078-0432.CCR-17-1100", "PMC5771949", "29113986"]}, {"Citation": "Pastorelli D., Fabricio A. S. C., Giovanis P., D\u2019Ippolito S., Fiduccia P., Solda C., et al. (2018). Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacol. Res. 132, 72\u201379. 10.1016/j.phrs.2018.03.013", "ArticleIdList": ["10.1016/j.phrs.2018.03.013", "29614381"]}, {"Citation": "Pezzani R., Salehi B., Vitalini S., Iriti M., Zuniga F. A., Sharifi-Rad J., et al. (2019). Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective. Med. (Kaunas) 55 (4), 110. 10.3390/medicina55040110", "ArticleIdList": ["10.3390/medicina55040110", "PMC6524059", "30999703"]}, {"Citation": "Pooladanda V., Bandi S., Mondi S. R., Gottumukkala K. M., Godugu C. (2018). Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer. Toxicol. In Vitro 51, 114\u2013128. 10.1016/j.tiv.2018.05.010", "ArticleIdList": ["10.1016/j.tiv.2018.05.010", "29778718"]}, {"Citation": "Prasad S., Yadav V. R., Sung B., Reuter S., Kannappan R., Deorukhkar A., et al. (2012). Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin. Cancer Res. 18 (18), 4942\u20134953. 10.1158/1078-0432.CCR-11-2805", "ArticleIdList": ["10.1158/1078-0432.CCR-11-2805", "PMC3677707", "22832932"]}, {"Citation": "Prasad S., Yadav V. R., Sung B., Gupta S. C., Tyagi A. K., Aggarwal B. B. (2016). Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment. Oncotarget 7 (11), 13182\u201313196. 10.18632/oncotarget.7537", "ArticleIdList": ["10.18632/oncotarget.7537", "PMC4914350", "26909608"]}, {"Citation": "Qazi A., Pal J., Maitah M., Fulciniti M., Pelluru D., Nanjappa P., et al. (2010). Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Trans. Oncol. 3 (6), 389\u2013399. 10.1593/tlo.10235", "ArticleIdList": ["10.1593/tlo.10235", "PMC3000464", "21151478"]}, {"Citation": "Saha A., Blando J., Silver E., Beltran L., Sessler J., DiGiovanni J. (2014). 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-kappaB signaling. Cancer Prev. Res. (Phila) 7 (6), 627\u2013638. 10.1158/1940-6207.CAPR-13-0420", "ArticleIdList": ["10.1158/1940-6207.CAPR-13-0420", "24691500"]}, {"Citation": "Sharma R. A., Euden S. A., Platton S. L., Cooke D. N., Shafayat A., Hewitt H. R., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10 (20), 6847\u20136854. 10.1158/1078-0432.CCR-04-0744", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0744", "15501961"]}, {"Citation": "Short N. J., Jabbour E., Naqvi K., Patel A., Ning J., Sasaki K., et al. (2019). A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Am. J. Hematol. 94 (1), 74\u201379. 10.1002/ajh.25318", "ArticleIdList": ["10.1002/ajh.25318", "PMC6570401", "30328139"]}, {"Citation": "Skroza N., Bernardini N., Proietti I., Potenza C. (2018). Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice. Ther. Clin. Risk Manag 14, 1879\u20131885. 10.2147/TCRM.S145779", "ArticleIdList": ["10.2147/TCRM.S145779", "PMC6174892", "30323610"]}, {"Citation": "Su J., Yan Y., Qu J., Xue X., Liu Z., Cai H. (2017). Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-kappaB pathway. Oncol. Rep. 37 (3), 1565\u20131572. 10.3892/or.2017.5428", "ArticleIdList": ["10.3892/or.2017.5428", "28184934"]}, {"Citation": "Su X., Jiang X., Meng L., Dong X., Shen Y., Xin Y. (2018). Anticancer activity of sulforaphane: the epigenetic mechanisms and the Nrf2 signaling pathway. Oxid. Med. Cell Longev 2018, 5438179. 10.1155/2018/5438179", "ArticleIdList": ["10.1155/2018/5438179", "PMC6011061", "29977456"]}, {"Citation": "Subramani R., Gonzalez E., Arumugam A., Nandy S., Gonzalez V., Medel J., et al. (2016). Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition. Sci. Rep. 6, 19819. 10.1038/srep19819", "ArticleIdList": ["10.1038/srep19819", "PMC4726267", "26804739"]}, {"Citation": "Suman S., Das T. P., Sirimulla S., Alatassi H., Ankem M. K., Damodaran C. (2016). Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells. Oncotarget 7 (12), 13854\u201313864. 10.18632/oncotarget.7351", "ArticleIdList": ["10.18632/oncotarget.7351", "PMC4924683", "26883103"]}, {"Citation": "Tao Y., Zhan S., Wang Y., Zhou G., Liang H., Chen X., et al. (2018). Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs. Sci. Rep. 8 (1), 14477. 10.1038/s41598-018-32734-2", "ArticleIdList": ["10.1038/s41598-018-32734-2", "PMC6160418", "30262902"]}, {"Citation": "Taverna S., Giallombardo M., Pucci M., Flugy A., Manno M., Raccosta S., et al. (2015). Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget 6 (26), 21918\u201321933. 10.18632/oncotarget.4204", "ArticleIdList": ["10.18632/oncotarget.4204", "PMC4673136", "26116834"]}, {"Citation": "Thangapazham R. L., Singh A. K., Sharma A., Warren J., Gaddipati J. P., Maheshwari R. K. (2007). Green tea polyphenols and its constituent Epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and. In vivo. Cancer Lett. 245, 232\u2013241. 10.1016/j.canlet.2006.01.027", "ArticleIdList": ["10.1016/j.canlet.2006.01.027", "16519995"]}, {"Citation": "Tozer G. M., Kanthou C., Parkins C. S., Hill S. A. (2002). The biology of the combretastatins as tumour vascular targeting agents. Int. J. Exp. Pathol. 83 (1), 21\u201338. 10.1046/j.1365-2613.2002.00211.x", "ArticleIdList": ["10.1046/j.1365-2613.2002.00211.x", "PMC2517662", "12059907"]}, {"Citation": "Tsai J. P., Lee C. H., Ying T. H., Lin C. L., Lin C. L., Hsueh J. T., et al. (2015). Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Oncotarget 6 (30), 28851\u201328866. 10.18632/oncotarget.4767", "ArticleIdList": ["10.18632/oncotarget.4767", "PMC4745696", "26311737"]}, {"Citation": "Tsang C. M., Cheung K. C., Cheung Y. C., Man K., Lui V. W., Tsao S. W., et al. (2015). Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. Biochim. Biophys. Acta 1852 (3), 541\u2013551. 10.1016/j.bbadis.2014.12.004", "ArticleIdList": ["10.1016/j.bbadis.2014.12.004", "25496992"]}, {"Citation": "van Agtmael M. A., Eggelte T. A., van Boxtel C. J. (1999). Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol. Sci. 20 (5), 199\u2013205. .10.1016/s0165-6147(99)01302-4", "ArticleIdList": ["10.1016/s0165-6147(99)01302-4", "10354615"]}, {"Citation": "Wang Y. C., Bachrach U. (2002). The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Amino Acids 22 (2), 131\u2013143. 10.1007/s007260200002", "ArticleIdList": ["10.1007/s007260200002", "12395181"]}, {"Citation": "Wang T., Jiang Y., Chu L., Wu T., You J. (2017). Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma. Am. J. Cancer Res. 7 (4), 999\u20131015.", "ArticleIdList": ["PMC5411806", "28469971"]}, {"Citation": "Wang Y., Wei Z., Wang X. (2018). Enhancement of anti-tumor activity of ursolic acid by nanostructured lipid carriers. China Nanomed. 2016: Nanotechnol. Biol. Med. 14, 1743\u20131885. 10.1016/j.nano.2017.11.366", "ArticleIdList": ["10.1016/j.nano.2017.11.366"]}, {"Citation": "Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. (1971). Plant antitumor agents. VI. the isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia. J. Am. Chem. Soc. 93 (9), 2325\u20132327. 10.1021/ja00738a045", "ArticleIdList": ["10.1021/ja00738a045", "5553076"]}, {"Citation": "Wen W., Lowe G., Roberts C. M., Finlay J., Han E. S., Glackin C. A., et al. (2017). Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer. Sci. Rep. 7 (1), 12754. 10.1038/s41598-017-12922-2", "ArticleIdList": ["10.1038/s41598-017-12922-2", "PMC5630613", "28986550"]}, {"Citation": "Wilken R., Veena M. S., Wang M. B., Srivatsan E. S. (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12. 10.1186/1476-4598-10-12", "ArticleIdList": ["10.1186/1476-4598-10-12", "PMC3055228", "21299897"]}, {"Citation": "Wu W., Tang S. N., Zhang Y., Puppala M., Cooper T. K., Xing C., et al. (2017). Prostate cancer xenograft inhibitory activity and pharmacokinetics of decursinol, a metabolite of angelica gigas pyranocoumarins, in mouse models. Am. J. Chin. Med. 45 (8), 1773\u20131792. 10.1142/S0192415X17500963", "ArticleIdList": ["10.1142/S0192415X17500963", "PMC6800172", "29121805"]}, {"Citation": "Wu J., Zhang X., Wang Y., Sun Q., Chen M., Liu S., et al. (2018. a). Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway. Oncol. Rep. 39 (3), 1181\u20131190. 10.3892/or.2017.6155", "ArticleIdList": ["10.3892/or.2017.6155", "29286170"]}, {"Citation": "Wu X., Wang W., Chen Y., Liu X., Wang J., Qin X., et al. (2018. b). Glycyrrhizin suppresses the growth of human NSCLC cell line HCC827 by downregulating HMGB1 level. BioMed. Res. Int. 2018, 6916797. 10.1155/2018/6916797", "ArticleIdList": ["10.1155/2018/6916797", "PMC5820661", "29568761"]}, {"Citation": "Xu Y., Ho C. T., Amin S. G., Han C., Chung F. L. (1992). Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J Mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52, 3875\u20133879. .10.1016/0169-5002(93)90327-T", "ArticleIdList": ["10.1016/0169-5002(93)90327-T", "1617663"]}, {"Citation": "Yallapu M. M., Maher D. M., Sundram V., Bell M. C., Jaggi M., Chauhan S. C. (2010). Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J. Ovarian Res. 3, 11. 10.1186/1757-2215-3-11", "ArticleIdList": ["10.1186/1757-2215-3-11", "PMC2880315", "20429876"]}, {"Citation": "Yan X-B., Xie T., Wang S. D., Wang Z., Li H. Y., Ye Z. M. (2018). Apigenin inhibits proliferation of human chondrosarcoma cells via cell cycle arrest and mitochondrial apoptosis induced by ROS generation-an in vitro and in vivo study. Int. J. Clin. Exp. Med. 11 (3), 1615\u20131631."}, {"Citation": "Youn D. H., Park J., Kim H. L., Jung Y., Kang J., Lim S., et al. (2018). Berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in vivo and in vitro. Front. Pharmacol. 9, 773. 10.3389/fphar.2018.00773", "ArticleIdList": ["10.3389/fphar.2018.00773", "PMC6054997", "30061836"]}, {"Citation": "Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J. Clin. Endocrinol. Metab. 93 (7), 2559\u20132565. 10.1210/jc.2007-2404", "ArticleIdList": ["10.1210/jc.2007-2404", "18397984"]}, {"Citation": "Zhang Y., Li Q., Zhou D., Chen H. (2013). Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/beta-catenin signalling and reduces colon pre-neoplasia in rats. Br. J. Nutr. 109 (1), 33\u201342. 10.1017/S0007114512000876", "ArticleIdList": ["10.1017/S0007114512000876", "22716201"]}, {"Citation": "Zhang J., Li L., Hale T. W., Chee W., Xing C., Jiang C., et al. (2015). Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women. PloS One 10 (2), e0114992. 10.1371/journal.pone.0114992", "ArticleIdList": ["10.1371/journal.pone.0114992", "PMC4335020", "25695490"]}, {"Citation": "Zhang B., Fan X., Wang Z., Zhu W., Li J. (2017. a). Alpinumisoflavone radiosensitizes esophageal squamous cell carcinoma through inducing apoptosis and cell cycle arrest. Biomed. Pharmacotherapy 95, 199\u2013206. 10.1016/j.biopha.2017.08.048", "ArticleIdList": ["10.1016/j.biopha.2017.08.048", "28843908"]}, {"Citation": "Zhang W., Su J., Xu H., Yu S., Liu Y., Zhang Y., et al. (2017. b). Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells. PloS One 12 (6), e0179672. 10.1371/journal.pone.0179672", "ArticleIdList": ["10.1371/journal.pone.0179672", "PMC5472302", "28617852"]}, {"Citation": "Zhang Y., Huang L., Shi H., Chen H., Tao J., Shen R., et al. (2018). Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance. Cancer Sci. 109 (1), 94\u2013102. 10.1111/cas.13425", "ArticleIdList": ["10.1111/cas.13425", "PMC5765292", "29034540"]}, {"Citation": "Zhao G., Han X., Zheng S., Li Z., Sha Y., Ni J., et al. (2016). Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol. Rep. 35 (2), 1065\u20131074. 10.3892/or.2015.4413", "ArticleIdList": ["10.3892/or.2015.4413", "26573768"]}, {"Citation": "Zhao Y., Jing Z., Lv J., Zhang Z., Lin J., Cao X., et al. (2017). Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo . Biomed. Pharmacotherapy 95, 18\u201324. 10.1016/j.biopha.2017.08.045", "ArticleIdList": ["10.1016/j.biopha.2017.08.045", "28826092"]}, {"Citation": "Zhu W., Qin W., Zhang K., Rottinghaus G. E., Chen Y. C., Kliethermes B., et al. (2012). Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr. Cancer 64 (3), 393\u2013400. 10.1080/01635581.2012.654926", "ArticleIdList": ["10.1080/01635581.2012.654926", "PMC3392022", "22332908"]}, {"Citation": "Zhu W. Q., Wang J., Guo X. F., Liu Z., Dong W. G. (2016). Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro . World J. Gastroenterol. 22 (16), 4149\u20134159. 10.3748/wjg.v22.i16.4149", "ArticleIdList": ["10.3748/wjg.v22.i16.4149", "PMC4837432", "27122665"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "13"}, {"Year": "2019", "Month": "12", "Day": "10"}, {"Year": "2020", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["32116665", "PMC7025531", "10.3389/fphar.2019.01614"]}}]}